Correction: Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study.
[This corrects the article DOI: 10.1371/journal.pone.0164455.].
Jesús
J
Troya
Pablo
P
Ryan
Esteban
E
Ribera
Daniel
D
Podzamczer
Victor
V
Hontañón
Jose Alberto
JA
Terrón
Vicente
V
Boix
Santiago
S
Moreno
Pilar
P
Barrufet
Manuel
M
Castaño
Ana
A
Carrero
María José
MJ
Galindo
Ignacio
I
Suárez-Lozano
Hernando
H
Knobel
Miguel
M
Raffo
Javier
J
Solís
María
M
Yllescas
Herminia
H
Esteban
Juan
J
González-García
Juan
J
Berenguer
Arkaitz
A
Imaz